Zobrazeno 1 - 7
of 7
pro vyhledávání: '"C J, Jolles"'
Publikováno v:
Oncology research. 8(1)
DNA topoisomerase I (topo I) is the molecular target for the camptothecin group of anticancer drugs. These drugs are showing activity against a wide array of human tumors. Many data have indicated that the sensitivity of a tumor cell to the camptothe
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 7(8)
DNA topoisomerase II is the molecular target of several clinically useful chemotherapeutic drugs. The sensitivity of cells to drugs that target topoisomerase II is dependent on the cellular content of this enzyme. Drug-sensitive cells have elevated a
Publikováno v:
The Journal of reproductive medicine. 35(3)
A premenopausal woman with recurrent stage II ductal breast carcinoma was treated with tamoxifen. After ten months of therapy her ovaries became acutely cystic and necrotic, but vascular torsion was not present. This case illustrates the special comp
Autor:
C J, Jolles
Publikováno v:
Seminars in oncology. 16(5)
Publikováno v:
Obstetrics and gynecology. 65(6)
A 59-year-old woman who presented with bowel obstruction, a large pelvic mass, and marked breast tenderness was found to have strikingly elevated preoperative serum concentrations of estrogen and progesterone. After resection of a primary adenocarcin
Publikováno v:
The Journal of reproductive medicine. 33(5)
The Estes procedure was designed to restore fertility in women with infertility related to tubal factors by transposition of an ovary into the uterine cavity with preservation of its vascular pedicle. This procedure was performed most commonly in the
Autor:
R S, Freedman, P B, Saul, C L, Edwards, C J, Jolles, D M, Gershenson, L A, Jones, E N, Atkinson, W J, Dana
Publikováno v:
Cancer treatment reports. 70(3)
Patients with ovarian carcinoma refractory to chemotherapy received a sequential combination of ethinyl estradiol and medroxyprogesterone acetate in two dose regimens. There was no difference in therapeutic activity of the two dose regimens. Of 65 pa